SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 153 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,183,000 | -12.0% | 373,523 | -13.5% | 0.61% | +8.7% |
| Q2 2017 | $4,752,000 | +22.3% | 431,996 | +9.0% | 0.56% | +48.0% |
| Q1 2017 | $3,884,000 | +87.8% | 396,336 | +107.0% | 0.38% | +120.2% |
| Q4 2016 | $2,068,000 | +0.8% | 191,474 | -4.3% | 0.17% | -11.7% |
| Q3 2016 | $2,052,000 | +6.3% | 200,170 | +35.5% | 0.20% | -26.0% |
| Q2 2016 | $1,930,000 | +90.0% | 147,772 | +60.0% | 0.26% | +90.6% |
| Q1 2016 | $1,016,000 | +29.1% | 92,356 | +8.0% | 0.14% | +39.0% |
| Q4 2015 | $787,000 | +1.3% | 85,541 | -23.6% | 0.10% | -18.7% |
| Q3 2015 | $777,000 | -45.7% | 111,985 | -23.2% | 0.12% | -47.4% |
| Q2 2015 | $1,432,000 | +137.5% | 145,821 | +114.4% | 0.23% | +200.0% |
| Q1 2015 | $603,000 | -68.5% | 68,007 | -75.5% | 0.08% | -75.2% |
| Q3 2014 | $1,915,000 | +1350.8% | 277,968 | +856.3% | 0.32% | +707.7% |
| Q1 2014 | $132,000 | +57.1% | 29,068 | +75.4% | 0.04% | +11.4% |
| Q4 2013 | $84,000 | -25.0% | 16,568 | -24.9% | 0.04% | -38.6% |
| Q3 2013 | $112,000 | +8.7% | 22,052 | +6.3% | 0.06% | -13.6% |
| Q2 2013 | $103,000 | – | 20,752 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|